Brand Summary

MD Hyperbaric offers a proven hyperbaric oxygen therapy (HBOT) franchise designed for healthcare professionals, entrepreneurs, and investors interested in wellness and regenerative medicine market. Founded in 2021 by Dr. Martin O’Malley—a board-certified orthopedic surgeon and team physician for the Brooklyn Nets and USA Basketball—MD Hyperbaric blends medical-grade innovation with a practical, scalable business model. It integrates smoothly into existing medical practices or as a standalone operation, offering strong profit margins, recurring revenue, and a unique service in the recovery and wellness field.

HBOT uses 100% oxygen under pressure to speed healing, boost recovery, and support a variety of health conditions and is a treatment used for over 400 years. The FDA , in the uS, approved it for 14 specific uses, but international research highlights its benefits for over 100 indications, from musculoskeletal injuries and neurological conditions to chronic illnesses and wellness goals. MD Hyperbaric sets itself apart in a split market: unlike hospitals with high-risk, oxygen-only chambers and restricted access, or med spas with low-pressure, unproven options, we provide medical-grade therapy in a comfortable setting with precise, science-backed protocols. Our approach relies on the OxyHealth Fortius420 chamber—one of the few FDA-cleared, ASME PVHO-1 approved models—trusted by over 500 elite athletes and 3,000 physicians worldwide.

The HBOT market in the U.S. offers a $15 billion opportunity, fueled by nearly half of all patients seeking treatments beyond the FDA’s 14 approved uses. Our diverse patient base includes those seeking injury or post-surgical recovery—often athletes and plastic surgery patients—alongside a growing demand for neurological conditions like TBI, concussion, and PTSD, and chronic conditions such as Long COVID and autoimmune diseases.